47 Life Sciences Companies
That Have Raised new funding
Track life sciences companies that recently received venture capital or growth funding in real-time.
Download this list
47 companies, each with its dated signal
Get 7 rows free · Recently Funded Life Sciences Companies
The list's first rows in Excel, with every column the full file has and how full each one is. One e-mail, then at most two short notes.
Need it kept current? See how Signal Tracker works
Other Signals in Life Sciences:
This page lists 47 life sciences companies that have raised new funding recently. Each company detected a recently funded signal through Bounce Watch's real-time monitoring system that tracks 40+ growth and risk indicators across thousands of companies.
Twist Bioscience
South San Francisco, United States (2013)
Synthetic DNA for Health & Sustainability
Juno Bio
London, United States (2018)
Juno Bio is the world's first and fastest vaginal microbiome testing company.
Myricx Bio
London, United Kingdom (2019)
Developing a new class of ADCs based on NMT inhibition to treat cancer
Aiforia Technologies
Finland (2013)
Translate images into data, discoveries, and diagnoses with deep learning AI for image analysis.
Apoha
London, United Kingdom (2021)
Teaching machines to see, feel, taste, smell, and understand matter.
Leyden Labs
The Netherlands (2020)
Freeing humanity from the burden of respiratory viruses
Element Biosciences
San Diego, United States (2017)
Opening the world of biology to new possibilities
Novoron Bioscience
San Diego, United States (2014)
Pioneering lipoprotein-receptor drug development to repair damage and degeneration to the brain, spinal c...
Absci
Vancouver, United States (2011)
Unlocking differentiated biology with generative AI
Track Recently Funded Signals in Real-Time
Get instant alerts when life sciences companies show recently funded activity. Monitor 40+ signal types across your target market.
Book a demo
Algorithmiq
Italy (2020)
Building the algorithmic layer that makes quantum computing useful.
EnteroBiotix
(2017)
Mastering the microbiome, transforming lives®
Cerevance
Boston, United States (2016)
Cerevance a neuroscience company
Living Carbon
United States (2019)
Public benefit company with a mission to fight climate change by enhancing CO2 capture and storage in tre...
Viseur AI - Digital Pathology Platform
Turkey (2024)
Better disease diagnosis for everyone!
Tubulis GmbH
Germany (2019)
Reimagining ADCs.
Revolution Medicines
Redwood City, United States (2014)
Translating Frontier Oncology Targets to Outsmart Cancer
Ajax Therapeutics
(2019)
Biopharmaceutical company developing next generation JAK inhibitors for patients with myeloproliferative...
Sana Biotechnology, Inc.
Seattle, United States (2018)
Focused on creating and delivering engineered cells as medicines for patients
Aspect Biosystems
Canada (2013)
Developing Bioprinted Tissue Therapeutics to transform how we treat some of the most elusive diseases.
Antiverse
Cardiff, United Kingdom (2017)
Designing functional antibodies for the most challenging targets.
Tessera Therapeutics
(2018)
Pioneering the future of genetic medicine with the power to rewrite the genome and cure diseases at their...
Crossbow Therapeutics, Inc
Cambridge, United States (2021)
Established antibody engineering to target the untapped universe of intracellular cancer targets, founded...
Atavistik Bio
Cambridge, United States (2021)
Precision allosteric therapeutics inspired by the body’s natural regulators
Qualisure Diagnostics Inc.
Calgary, Canada (2017)
Deploying AI-enabled molecular diagnostics globally through decentralized testing and centralized interpr...
Bicara Therapeutics
Boston, United States (2020)
Pioneering bifunctional antibodies for targeted tumor modulation
Arcellx
Redwood City, United States (2015)
Arcellx is a clinical-stage biotechnology company based in Redwood City, California
Evommune
Palo Alto, United States (2020)
Developing innovative therapies that target key drivers of chronic inflammatory diseases.
eco:fibr
Hannover, Germany (2022)
turning waste into purpose - for one sustainable world.
Complete Genomics
San Jose, United States (2005)
Driving genomics forward with complete sequencing solutions
Juisci
(2021)
Your daily Juice of Science available anytime, anywhere.
Alvotech
Iceland (2013)
Better Access. Better Lives.
Automata
London, United Kingdom (2015)
Where legacy ends, Automata begins.
Nuclera
Cambridge, United Kingdom (2013)
Bring rapid protein access to your benchtop with eProtein Discovery
FluoSphera
Geneva, Switzerland (2021)
The only company with a suite of systemic and high-throughput in vitro drug discovery solutions
ALX Oncology
South San Francisco, United States (2015)
ALX Oncology is a clinical-stage biotechnology company advancing cancer therapies by boosting the immune...
Think Bioscience
Boulder, United States (2019)
Natural Medicines Reimagined
Vizgen
Cambridge, United States (2019)
Confidently take your research to new depths with MERSCOPE Ultra integrating single-cell and spatial mult...
Bayer
Leverkusen, Germany (1863)
Global enterprise with core competencies in the Life Science fields of health care and agriculture
Coya Therapeutics, Inc.
Houston, United States (2020)
Unleashing the power of Tregs to tackle neurodegenerative and autoimmune diseases.
Testmate Health
Lausanne, Switzerland (2020)
Testmate is pioneering the next generation of low-cost tests, starting with sexual health & women's healt...
Arctoris
United Kingdom (2016)
Arctoris is a tech-enabled Partnership Research Organization (PRO) headquartered in Oxford, UK.
Pharvaris
Zug, Switzerland (2015)
Pioneering science for patient choice
Taysha Gene Therapies
Dallas, United States (2020)
Taysha Gene Therapies is focused on advancing AAV-based gene therapies for severe monogenic diseases of t...
Nuage Therapeutics
Spain (2021)
We develop new selective and potent drugs for intrinsically disordered targets.
mend™
New York, United States (2018)
Advancing patient healing through clinically supported nutrition and care.
Parse Biosciences
Seattle, United States (2018)
Scalable Single Cell Sequencing Without the Instrument
Annexon Biosciences
South San Francisco, United States (2011)
Unlocking the Next Generation of Complement Therapies
What changed at these Life Sciences companies recently?
We recorded 140 changes here in the last 180 days, including 46 product launches, 32 awards, 13 traction updates, 12 milestones and 10 funding events. Each entry below carries the date we observed it, from public sources.
-
Twist Bioscience
— Growth Metrics Shared
-
Aiforia Technologies
— New Feature Launched
-
Absci
— Regulatory Approval
-
Automata
— New Feature Launched
-
Leyden Labs
— Growth Metrics Shared
-
Revolution Medicines
— Regulatory Approval
-
Nuclera
— Award Received
-
eco:fibr
— Accepted to Program